2011/10/21 09:51:17 | |
---|---|
Price | |
74.0753 SGD | |
Difference | 0.00% (0.00) |
ISIN | CH0013841017 |
Symbol | LONN |
Exchange | Singapore Exchange |
Currency | SGD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 39,512 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 79.97 SGD (10) |
Ask (Ask size) | 76.8820 SGD (540) |
Open | 79.97 SGD |
High | 79.97 SGD |
Low | 79.97 SGD |
Close (prev. day) | 74.0753 SGD |
VWAP | 74.075331 SGD |
Volume (pcs) | 540 |
Trading volume | 39.99 |
Number of trades | 1 |
Last size | 540 |
Related Futures | 30 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/24 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2011/10/21 09:51:17 | |
---|---|
Price | |
74.0753 SGD | |
Difference | 0.00% (0.00) |
ISIN | CH0013841017 |
Symbol | LONN |
Exchange | Singapore Exchange |
Currency | SGD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 39,512 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | 79.97 SGD (10) |
Ask (Ask size) | 76.8820 SGD (540) |
Open | 79.97 SGD |
High | 79.97 SGD |
Low | 79.97 SGD |
Close (prev. day) | 74.0753 SGD |
VWAP | 74.075331 SGD |
Volume (pcs) | 540 |
Trading volume | 39.99 |
Number of trades | 1 |
Last size | 540 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.95 | 1.38 | 1.37 |
Volatility | - | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | - SGD (-) |
Ø price 30 days | Ø volume 30 days (pcs.) | - SGD (-) |
Ø price 100 days | Ø volume 100 days (pcs.) | - SGD (-) |
Ø price 250 days | Ø volume 250 days (pcs.) | - SGD (-) |
YTD High | date | - SGD (-) |
YTD Low | date | - SGD (-) |
52 Weeks High | date | - SGD (-) |
52 Weeks Low | date | - SGD (-) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2019/06/28 | 18:45 | 296.90 EUR | 0.00 | 14 |
Duesseldorf | 2019/06/28 | 08:11 | 291.20 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/08/16 | 18:37 | 647.675 USD | 0.02 | 2 |
Frankfurt | 2019/06/28 | 15:56 | 293.90 EUR | 0.02 | 4 |
Hamburg | 2019/06/28 | 08:01 | 291.30 EUR | 0.00 | 2 |
London Stock Exchange | 2024/08/13 | 15:36 | 544.50 CHF | 0.78 | 1 |
SIX Swiss Exchange | 2024/08/16 | 17:31 | 549.80 CHF | 63.71 | 3,168 |
Singapore Exchange | 2011/10/21 | 09:51 | 74.0753 SGD | 0.00 | 1 |
LONZA GROUP AG |
- - |
Muenchensteinerstrasse 38 - 4002 Basel |
Telefon: +41-61-316-81-11 |
Fax: +41-61-316-91-11 |
E-mail: media@lonza.com |
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland. |
Wolfgang Wienand | Chairman of Managing Board |
Christian Seufert | Member of Executive Committee |
Daniel Palmacci | Member of Executive Committee |
Gordon Bates | Member of Executive Committee |
Jean-Christophe Hyvert | Member of Executive Committee |
Maria Soler Nunez | Member of Executive Committee |
Philippe Deecke | Member of Executive Committee |
Angelica Kohlmann | Member of the administrative board |
Marion Helmes | Member of the administrative board |
Olivier Verscheure | Member of the administrative board |
Roger Nitsch | Member of the administrative board |
Barbara Richmond | Member of the administrative board |
Christoph Mäder | Member of the administrative board |
Jürgen B. Steinemann | Member of the administrative board |
R. Jean-Marc Sidney Huët | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer